Wave Life Sciences WVE Rest Of World — Current Income Tax Expense Benefit

Similar metrics at other companies

NOVTOther Countries — Current Income Tax Expense Benefit

$5.73M+16.7%

IOSPRest Of World — Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

$11.23M+284%

ENBOther Countries — Foreign Income Tax Expense Benefit Continuing Operations

-200,000,000%-3,400,000,000pp

NTAPOther Countries — Foreign Income Tax Expense Benefit Continuing Operations

$17.5M—

AESNon-US — Income Tax Expense (Benefit)

$6.5M-7.1%

SMRForeign Income Tax Expense Benefit Continuing Operations

$0-100%

Questions, answered.

What is Wave Life Sciences's rest of world — current income tax expense benefit?

Wave Life Sciences (WVE) reported rest of world — current income tax expense benefit of $0 in Q4 2025.

What is the long-term trend for Wave Life Sciences's rest of world — current income tax expense benefit?

Over 4 years (2021 to 2025), Wave Life Sciences's rest of world — current income tax expense benefit has grown at a -100.0% compound annual growth rate (CAGR), from -$204K to $0.

What does rest of world — current income tax expense benefit mean?

This metric reflects the actual income tax liability or benefit incurred by the company's 'Rest of World' segment for the current reporting period. It captures the immediate tax impact of operations within these specific international jurisdictions based on local tax laws. Monitoring this helps investors understand the effective tax burden associated with the company's global footprint and regional regulatory environments.